LABORATORY CRP OF AMER HLDGS (LH)
US50540R4092 - Common Stock
LH Stock Earnings: Laboratory Corp Beats EPS, Beats Revenue for Q1 2024
LH stock results show that Laboratory Corp beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Labcorp Announces 2024 First Quarter Results
Updates Full-Year Guidance Results from Continuing Operations for first quarter 2024 versus last year: Revenue: $3.18 billion versus $3.04 billion or up 4.6% |...
Labcorp Announces Winning Bid for Select Assets of Invitae
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the...
Invitae Enters into Agreement with Labcorp for Sale of Business
/PRNewswire/ -- Invitae (OTC:NVTA), a leading medical genetics company, announced that Labcorp (NYSE: LH), a global leader of innovative and comprehensive...
Interesting LH Put And Call Options For June 21st
Laboratory Corporation of America Holdings Enters Oversold Territory (LH)
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the availability of the nation's first...
Labcorp Declares Quarterly Dividend
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has...
Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the U.S. Food and Drug Administration...
Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the strategic expansion of its...
Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Labcorp® Plasma Detect™,...
Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp
The Prelude Network® Names Labcorp Its Preferred Genetic Carrier Screening Lab
/PRNewswire/ -- The Prelude Network® (Prelude), the largest network of fertility clinics in North America, announced today an expansion of its partnership with...
Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational...
Labcorp to Announce First Quarter Financial Results on April 25, 2024
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the first...
Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch and immediate availability...
Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian Cancer
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today presented the results from two studies at the...
Labcorp Launches Weight Loss Management Testing Solutions
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the introduction of its Weight Loss...
PINNACLE FERTILITY PARTNERS WITH LABCORP TO ENHANCE GENETIC TESTING SERVICES
/PRNewswire/ -- Pinnacle Fertility, a leading network of high-performing family-building clinics, recently announced a strategic partnership with Labcorp, a...
Labcorp Announces 2023 Fourth Quarter and Full Year Results
Company Provides 2024 Guidance Results from Continuing Operations for the fourth quarter and full year versus last year: Revenue: Q4 of $3.03 billion vs $2.93...
Labcorp Launches New Test for Risk Assessment and Prognosis of Severe Preeclampsia in Pregnant Women
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the launch and availability of a new,...
LH March 15th Options Begin Trading
Laboratory Corporation of America Holdings Takes Over #348 Spot From Cooper Companies
Labcorp to Announce Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth...
Laboratory Corporation of America declares $0.72 dividend (NYSE:LH)
Laboratory Corporation of America (LH) declares $0.72/share quarterly dividend, in line with previous. Forward yield 1.29% Payable March 13; for shareholders of
Labcorp Declares Quarterly Dividend
/PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors has declared a cash dividend of $0.72...
Labcorp, Hawthorne Effect team up to make clinical trials more accessible (NYSE:LH)
Labcorp (LH) and Hawthorne Effect have partnered to help make clinical trials more diverse and accessible by decentralizing clinical testing sites. Read more here.
Labcorp to Speak at the 42nd Annual J.P. Morgan Healthcare Conference
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive...
SomaLogic Issues Statement Correcting Madryn Asset Management's Misleading Disclosure
/PRNewswire/ -- SomaLogic, Inc. (Nasdaq: SLGC), a leader in proteomics technology, today issued the following statement in response to a press release issued...